Global and Region Human Vaccines Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).

    The report details the trend, potential and market size of Human Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Human Vaccinesmarket, defines the market attractiveness level of Human Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Human Vaccines industry, describes the types of Human Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Human Vaccines market and the development prospects and opportunities of Human Vaccines industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Human Vaccines market in Chapter 13.

    By Player:

    • Changsheng Life

    • CNBG

    • SINOVAC BIOTECH

    • Hissen

    • Walvax Biotechnology

    • Zhongyianke Biotech

    • Adimmune

    • ChengDa Bio

    • SANOFI

    • NuoCheng Bio

    • Hualan Bio

    • Tiantan biological

    • Rong An

    • Kangtai

    • GSK

    • Zhifei

    • Changchun Baike

    By Type:

    • Varicella

    • Influenza

    • Polio

    • Hepatitis A

    • Rabies

    • BCG

    • Hepatitis B

    • Other

    By End-User:

    • Adults

    • Children

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Human Vaccines Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Human Vaccines Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Human Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Human Vaccines Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Human Vaccines Market Analysis and Outlook to 2022

    • 7.1 Global Human Vaccines Consumption (2017-2022)

    • 7.2 United States Human Vaccines Consumption (2017-2022)

    • 7.3 Europe Human Vaccines Consumption (2017-2022)

    • 7.4 China Human Vaccines Consumption (2017-2022)

    • 7.5 Japan Human Vaccines Consumption (2017-2022)

    • 7.6 India Human Vaccines Consumption (2017-2022)

    • 7.7 South Korea Human Vaccines Consumption (2017-2022)

    8 Region and Country-wise Human Vaccines Market Analysis and Outlook to 2028

    • 8.1 Global Human Vaccines Consumption Forecast (2022-2028)

    • 8.2 United States Human Vaccines Consumption Forecast (2022-2028)

    • 8.3 Europe Human Vaccines Consumption Forecast (2022-2028)

    • 8.4 China Human Vaccines Consumption Forecast (2022-2028)

    • 8.5 Japan Human Vaccines Consumption Forecast (2022-2028)

    • 8.6 India Human Vaccines Consumption Forecast (2022-2028)

    • 8.7 South Korea Human Vaccines Consumption Forecast (2022-2028)

    9 Global Human Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Human Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Varicella Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Influenza Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Polio Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Hepatitis A Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Rabies Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global BCG Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Hepatitis B Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Human Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Adults Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Children Consumption and Growth Rate (2017-2022)

    10 Global Human Vaccines Market Outlook by Types and Applications to 2028

    • 10.1 Global Human Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Varicella Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Influenza Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Polio Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Hepatitis A Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Rabies Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global BCG Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Hepatitis B Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Human Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Adults Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Children Consumption Forecast and Growth Rate (2022-2028)

    11 Global Human Vaccines Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Human Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Human Vaccines Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Human Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Human Vaccines Market Competitive Analysis

    • 14.1 Changsheng Life

      • 14.1.1 Changsheng Life Company Details

      • 14.1.2 Changsheng Life Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Changsheng Life Human Vaccines Product and Service

    • 14.2 CNBG

      • 14.2.1 CNBG Company Details

      • 14.2.2 CNBG Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 CNBG Human Vaccines Product and Service

    • 14.3 SINOVAC BIOTECH

      • 14.3.1 SINOVAC BIOTECH Company Details

      • 14.3.2 SINOVAC BIOTECH Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 SINOVAC BIOTECH Human Vaccines Product and Service

    • 14.4 Hissen

      • 14.4.1 Hissen Company Details

      • 14.4.2 Hissen Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Hissen Human Vaccines Product and Service

    • 14.5 Walvax Biotechnology

      • 14.5.1 Walvax Biotechnology Company Details

      • 14.5.2 Walvax Biotechnology Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Walvax Biotechnology Human Vaccines Product and Service

    • 14.6 Zhongyianke Biotech

      • 14.6.1 Zhongyianke Biotech Company Details

      • 14.6.2 Zhongyianke Biotech Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Zhongyianke Biotech Human Vaccines Product and Service

    • 14.7 Adimmune

      • 14.7.1 Adimmune Company Details

      • 14.7.2 Adimmune Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Adimmune Human Vaccines Product and Service

    • 14.8 ChengDa Bio

      • 14.8.1 ChengDa Bio Company Details

      • 14.8.2 ChengDa Bio Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 ChengDa Bio Human Vaccines Product and Service

    • 14.9 SANOFI

      • 14.9.1 SANOFI Company Details

      • 14.9.2 SANOFI Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 SANOFI Human Vaccines Product and Service

    • 14.10 NuoCheng Bio

      • 14.10.1 NuoCheng Bio Company Details

      • 14.10.2 NuoCheng Bio Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 NuoCheng Bio Human Vaccines Product and Service

    • 14.11 Hualan Bio

      • 14.11.1 Hualan Bio Company Details

      • 14.11.2 Hualan Bio Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Hualan Bio Human Vaccines Product and Service

    • 14.12 Tiantan biological

      • 14.12.1 Tiantan biological Company Details

      • 14.12.2 Tiantan biological Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Tiantan biological Human Vaccines Product and Service

    • 14.13 Rong An

      • 14.13.1 Rong An Company Details

      • 14.13.2 Rong An Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Rong An Human Vaccines Product and Service

    • 14.14 Kangtai

      • 14.14.1 Kangtai Company Details

      • 14.14.2 Kangtai Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Kangtai Human Vaccines Product and Service

    • 14.15 GSK

      • 14.15.1 GSK Company Details

      • 14.15.2 GSK Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 GSK Human Vaccines Product and Service

    • 14.16 Zhifei

      • 14.16.1 Zhifei Company Details

      • 14.16.2 Zhifei Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Zhifei Human Vaccines Product and Service

    • 14.17 Changchun Baike

      • 14.17.1 Changchun Baike Company Details

      • 14.17.2 Changchun Baike Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Changchun Baike Human Vaccines Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Human Vaccines

    • Figure Human Vaccines Picture

    • Table Global Human Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Human Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Human Vaccines Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Human Vaccines Consumption by Country (2017-2022)

    • Figure United States Human Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Human Vaccines Consumption and Growth Rate (2017-2022)

    • Figure China Human Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Human Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Human Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Human Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Human Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Human Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Human Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Human Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Human Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Human Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Human Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Varicella Consumption and Growth Rate (2017-2022)

    • Figure Global Influenza Consumption and Growth Rate (2017-2022)

    • Figure Global Polio Consumption and Growth Rate (2017-2022)

    • Figure Global Hepatitis A Consumption and Growth Rate (2017-2022)

    • Figure Global Rabies Consumption and Growth Rate (2017-2022)

    • Figure Global BCG Consumption and Growth Rate (2017-2022)

    • Figure Global Hepatitis B Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Adults Consumption and Growth Rate (2017-2022)

    • Figure Global Children Consumption and Growth Rate (2017-2022)

    • Figure Global Varicella Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Influenza Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Polio Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hepatitis A Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rabies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BCG Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hepatitis B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Children Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Human Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Human Vaccines Export by Region (Top 5 Countries) (2017-2028)

    • Table Changsheng Life (Foundation Year, Company Profile and etc.)

    • Table Changsheng Life Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Changsheng Life Human Vaccines Product and Service

    • Table CNBG (Foundation Year, Company Profile and etc.)

    • Table CNBG Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table CNBG Human Vaccines Product and Service

    • Table SINOVAC BIOTECH (Foundation Year, Company Profile and etc.)

    • Table SINOVAC BIOTECH Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table SINOVAC BIOTECH Human Vaccines Product and Service

    • Table Hissen (Foundation Year, Company Profile and etc.)

    • Table Hissen Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hissen Human Vaccines Product and Service

    • Table Walvax Biotechnology (Foundation Year, Company Profile and etc.)

    • Table Walvax Biotechnology Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Walvax Biotechnology Human Vaccines Product and Service

    • Table Zhongyianke Biotech (Foundation Year, Company Profile and etc.)

    • Table Zhongyianke Biotech Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zhongyianke Biotech Human Vaccines Product and Service

    • Table Adimmune (Foundation Year, Company Profile and etc.)

    • Table Adimmune Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Adimmune Human Vaccines Product and Service

    • Table ChengDa Bio (Foundation Year, Company Profile and etc.)

    • Table ChengDa Bio Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table ChengDa Bio Human Vaccines Product and Service

    • Table SANOFI (Foundation Year, Company Profile and etc.)

    • Table SANOFI Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table SANOFI Human Vaccines Product and Service

    • Table NuoCheng Bio (Foundation Year, Company Profile and etc.)

    • Table NuoCheng Bio Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table NuoCheng Bio Human Vaccines Product and Service

    • Table Hualan Bio (Foundation Year, Company Profile and etc.)

    • Table Hualan Bio Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hualan Bio Human Vaccines Product and Service

    • Table Tiantan biological (Foundation Year, Company Profile and etc.)

    • Table Tiantan biological Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tiantan biological Human Vaccines Product and Service

    • Table Rong An (Foundation Year, Company Profile and etc.)

    • Table Rong An Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Rong An Human Vaccines Product and Service

    • Table Kangtai (Foundation Year, Company Profile and etc.)

    • Table Kangtai Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kangtai Human Vaccines Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Human Vaccines Product and Service

    • Table Zhifei (Foundation Year, Company Profile and etc.)

    • Table Zhifei Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zhifei Human Vaccines Product and Service

    • Table Changchun Baike (Foundation Year, Company Profile and etc.)

    • Table Changchun Baike Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Changchun Baike Human Vaccines Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.